Proceedings of workshop: "Neuroglycoproteins in health and disease", INNOGLY cost action.

Cancer Glyco-enzimes Glycosylation Lectins Mass-spectrometry NMR Neurodegenerative diseases

Journal

Glycoconjugate journal
ISSN: 1573-4986
Titre abrégé: Glycoconj J
Pays: United States
ID NLM: 8603310

Informations de publication

Date de publication:
10 2022
Historique:
received: 26 07 2022
accepted: 28 07 2022
revised: 26 07 2022
pubmed: 25 8 2022
medline: 16 9 2022
entrez: 24 8 2022
Statut: ppublish

Résumé

The Cost Action "Innovation with glycans: new frontiers from synthesis to new biological targets" (INNOGLY) hosted the Workshop "Neuroglycoproteins in health and disease", in Alicante, Spain, on March 2022. This event brought together an european group of scientists that presented novel insights into changes in glycosylation in diseases of the central nervous system and cancer, as well as new techniques to study protein glycosylation. Herein we provide the abstracts of all the presentations.

Identifiants

pubmed: 36001187
doi: 10.1007/s10719-022-10078-4
pii: 10.1007/s10719-022-10078-4
pmc: PMC9399589
doi:

Substances chimiques

Polysaccharides 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

579-586

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Schengrund, C.L., Rosenberg, A.: Intracellular location and properties of bovine brain sialidase. J. Biol. Chem. 245, 6196–6200 (1970). https://doi.org/10.1016/s0021-9258(18)62678-x
doi: 10.1016/s0021-9258(18)62678-x pubmed: 5484473
Tettamanti, G., Morgan, I.G., Gombos, G., Mandel, P.: Sub-synaptosomal localization of brain particulate neuraminidose. Brain Res. 47, 515–518 (1972). https://doi.org/10.1016/0006-8993(72)90661-0
doi: 10.1016/0006-8993(72)90661-0 pubmed: 4642578
Tettamanti, G., Preti, A., Lombardo, A., Bonali, F., Zambotti, V.: Parallelism of subcellular location of major particulate neuraminidase and gangliosides in rabbit brain cortex. Biochim. Biophys. Acta. 306, 466–477 (1973). https://doi.org/10.1016/0005-2760(73)90185-9
doi: 10.1016/0005-2760(73)90185-9 pubmed: 4726869
Tettamanti, G., Preti, A., Lombardo, A., Suman, T., Zambotti, V.: Membrane-bound neuraminidase in the brain of different animals: behaviour of the enzyme on endogenous sialo derivatives and rationale for its assay. J. Neurochem. 25, 451–456 (1975). https://doi.org/10.1111/J.1471-4159.1975.TB04349.X
doi: 10.1111/J.1471-4159.1975.TB04349.X pubmed: 1151380
Preti, A., Fiorilli, A., Lombardo, A., Caimi, L., Tettamanti, G.: Occurrence of sialyltransferase activity in the synaptosomal membranes prepared from calf brain cortex. J. Neurochem. 35, 281–296 (1980). https://doi.org/10.1111/J.1471-4159.1980.TB06263.X
doi: 10.1111/J.1471-4159.1980.TB06263.X pubmed: 6161218
Venable, M.E., Lee, J.Y., Smyth, M.J., Bielawska, A., Obeid, L.M.: Role of ceramide in cellular senescence. J. Biol. Chem. 270, 30701–30708 (1995). https://doi.org/10.1074/JBC.270.51.30701
doi: 10.1074/JBC.270.51.30701 pubmed: 8530509
Samarani, M., Loberto, N., Soldà, G., Straniero, L., Asselta, R., Duga, S., Lunghi, G., Zucca, F.A., Mauri, L., Ciampa, M.G., Schiumarini, D., Bassi, R., Giussani, P., Chiricozzi, E., Prinetti, A., Aureli, M., Sonnino, S.: A lysosome-plasma membrane-sphingolipid axis linking lysosomal storage to cell growth arrest. FASEB J. 32, 5685–5702 (2018). https://doi.org/10.1096/FJ.201701512RR
doi: 10.1096/FJ.201701512RR pubmed: 29746165 pmcid: 6133699
Aureli, M., Loberto, N., Bassi, R., Ferraretto, A., Perego, S., Lanteri, P., Chigorno, V., Sonnino, S., Prinetti, A.: Plasma membrane-associated glycohydrolases activation by extracellular acidification due to proton exchangers. Neurochem. Res. 37, 1296–1307 (2012). https://doi.org/10.1007/S11064-012-0725-1
doi: 10.1007/S11064-012-0725-1 pubmed: 22359055
Sonnino, S., Cantù, L., Corti, M., Acquotti, D., Venerando, B.: Aggregative properties of gangliosides in solution. Chem. Phys. Lipids. 71, 21–45 (1994). https://doi.org/10.1016/0009-3084(94)02304-2
doi: 10.1016/0009-3084(94)02304-2 pubmed: 8039256
Brocca, P., Sonnino, S.: Dynamics and Spatial Organization of Surface Gangliosides. Trends Glycosci. Glycotechnol. 9, 433–445 (1997). https://doi.org/10.4052/TIGG.9.433
doi: 10.4052/TIGG.9.433
Scott, H., Panin, V.M.: The role of protein N-glycosylation in neural transmission. Glycobiology 24, 407–417 (2014). https://doi.org/10.1093/GLYCOB/CWU015
doi: 10.1093/GLYCOB/CWU015 pubmed: 24643084 pmcid: 3976283
Scott, H., Panin, V.M.: N-glycosylation in regulation of the nervous system. Adv. Neurobiol. 9, 367–394 (2014). https://doi.org/10.1007/978-1-4939-1154-7_17
doi: 10.1007/978-1-4939-1154-7_17 pubmed: 25151388 pmcid: 4476505
Kleene, R., Schachner, M.: Glycans and neural cell interactions. Nat. Rev. Neurosci. 5, 195–208 (2004). https://doi.org/10.1038/NRN1349
doi: 10.1038/NRN1349 pubmed: 14976519
Iqbal, S., Fard, M.G., Everest-Dass, A., Packer, N.H., Parker, L.M.: Understanding cellular glycan surfaces in the central nervous system. Biochem. Soc. Trans. 47, 89–100 (2019). https://doi.org/10.1042/BST20180330
doi: 10.1042/BST20180330 pubmed: 30559272
O’flaherty, R., Simon, Á., Alonso-Sampedro, M., Sánchez-Batán, S., Fernández-Merino, C., Gude, F., Saldova, R., González-Quintela, A.: Changes in serum N-Glycome for risk drinkers: A comparison with standard markers for alcohol abuse in men and women. Biomolecules. 12, (2022). https://doi.org/10.3390/BIOM12020241
Park, D.S., Poretz, R.D., Stein, S., Nora, R., Manowitz, P.: Association of alcoholism with the N-glycosylation polymorphism of pseudodeficient human arylsulfatase A. Alcohol. Clin. Exp. Res. 20, 228–233 (1996). https://doi.org/10.1111/J.1530-0277.1996.TB01634.X
doi: 10.1111/J.1530-0277.1996.TB01634.X pubmed: 8730212
Váradi, C., Nehéz, K., Hornyák, O., Viskolcz, B., Bones, J.: Serum N-Glycosylation in parkinson’s disease: A novel approach for potential alterations. Molecules. 24, (2019). https://doi.org/10.3390/MOLECULES24122220
Samal, J., Saldova, R., Rudd, P.M., Pandit, A., O’Flaherty, R.: Region-Specific Characterization of N-Glycans in the Striatum and Substantia Nigra of an Adult Rodent Brain. Anal. Chem. 92, 12842–12851 (2020). https://doi.org/10.1021/ACS.ANALCHEM.0C01206
doi: 10.1021/ACS.ANALCHEM.0C01206 pubmed: 32815717
Hawkinson, T.R., Clarke, H.A., Young, L.E.A., Conroy, L.R., Markussen, K.H., Kerch, K.M., Johnson, L.A., Nelson, P.T., Wang, C., Allison, D.B., Gentry, M.S., Sun, R.C.: In situ spatial glycomic imaging of mouse and human Alzheimer’s disease brains. Alzheimers. Dement. (2021). https://doi.org/10.1002/ALZ.12523
doi: 10.1002/ALZ.12523 pubmed: 34908231
Rebelo, A.L., Gubinelli, F., Roost, P., Jan, C., Brouillet, E., Van Camp, N., Drake, R.R., Saldova, R., Pandit, A.: Complete spatial characterisation of N-glycosylation upon striatal neuroinflammation in the rodent brain. J. Neuroinflammation. 18, (2021). https://doi.org/10.1186/S12974-021-02163-6
Williams, S.E., Mealer, R.G., Scolnick, E.M., Smoller, J.W., Cummings, R.D.: Aberrant glycosylation in schizophrenia: a review of 25 years of post-mortem brain studies. Mol. Psychiatry. 25, 3198–3207 (2020). https://doi.org/10.1038/S41380-020-0761-1
doi: 10.1038/S41380-020-0761-1 pubmed: 32404945 pmcid: 8081047
Goldberg, D.P., Bridges, K., Duncan-Jones, P., Grayson, D., Goldberg, D.P., Bridges, K., Duncan-Jones, P., Grayson, D.: Dimensions of neuroses seen in primary-care settings. Psychol. Med. 17, 461–470 (1987). https://doi.org/10.1017/S0033291700025022
doi: 10.1017/S0033291700025022 pubmed: 3602238
Zhu, Y., Shan, X., Yuzwa, S.A., Vocadlo, D.J.: The emerging link between O-GlcNAc and Alzheimer disease. J. Biol. Chem. 289, 34472–34481 (2014). https://doi.org/10.1074/jbc.R114.601351
doi: 10.1074/jbc.R114.601351 pubmed: 25336656 pmcid: 4263855
Broncel, M., Falenski, J.A., Wagner, S.C., Hackenberger, C.P.R., Koksch, B.: How post-translational modifications influence amyloid formation: a systematic study of phosphorylation and glycosylation in model peptides. Chemistry 16, 7881–7888 (2010). https://doi.org/10.1002/CHEM.200902452
doi: 10.1002/CHEM.200902452 pubmed: 20491120
Gong, C.X., Liu, F., Grundke-Iqbal, I., Iqbal, K.: Impaired brain glucose metabolism leads to Alzheimer neurofibrillary degeneration through a decrease in tau O-GlcNAcylation. J. Alzheimers. Dis. 9, 1–12 (2006). https://doi.org/10.3233/JAD-2006-9101
doi: 10.3233/JAD-2006-9101 pubmed: 16627930
Frenkel-Pinter, M., Richman, M., Belostozky, A., Abu-Mokh, A., Gazit, E., Rahimipour, S., Segal, D.: Selective Inhibition of Aggregation and Toxicity of a Tau-Derived Peptide using Its Glycosylated Analogues. Chemistry 22, 5945–5952 (2016). https://doi.org/10.1002/CHEM.201504950
doi: 10.1002/CHEM.201504950 pubmed: 26891276
Frenkel-Pinter, M., Shmueli, M.D., Raz, C., Yanku, M., Zilberzwige, S., Gazit, E., Segal, D.: Interplay between protein glycosylation pathways in Alzheimer’s disease. Sci. Adv. 3, (2017). https://doi.org/10.1126/SCIADV.1601576
Frenkel-Pinter, M., Richman, M., Belostozky, A., Abu-Mokh, A., Gazit, E., Rahimipour, S., Segal, D.: Distinct Effects of O-GlcNAcylation and Phosphorylation of a Tau-Derived Amyloid Peptide on Aggregation of the Native Peptide. Chemistry 24, 14039–14043 (2018). https://doi.org/10.1002/CHEM.201802209
doi: 10.1002/CHEM.201802209 pubmed: 30144161
Zhao, J., Patwa, T.H., Qiu, W., Shedden, K., Hinderer, R., Misek, D.E., Anderson, M.A., Simeone, D.M., Lubman, D.M.: Glycoprotein microarrays with multi-lectin detection: unique lectin binding patterns as a tool for classifying normal, chronic pancreatitis and pancreatic cancer sera. J. Proteome Res. 6, 1864–1874 (2007). https://doi.org/10.1021/PR070062P
doi: 10.1021/PR070062P pubmed: 17428079
Tao, S.C., Li, Y., Zhou, J., Qian, J., Schnaar, R.L., Zhang, Y., Goldstein, I.J., Zhu, H., Schneck, J.P.: Lectin microarrays identify cell-specific and functionally significant cell surface glycan markers. Glycobiology 18, 761–769 (2008). https://doi.org/10.1093/GLYCOB/CWN063
doi: 10.1093/GLYCOB/CWN063 pubmed: 18625848 pmcid: 2733773
Ngoh, G.A., Hamid, T., Prabhu, S.D., Jones, S.P.: O-GlcNAc signaling attenuates ER stress-induced cardiomyocyte death. Am. J. Physiol. Heart Circ. Physiol. 297, (2009). https://doi.org/10.1152/AJPHEART.00553.2009
Soreq, H., Seidman, S.: Acetylcholinesterase--new roles for an old actor. Nat. Rev. Neurosci. 2, 294–302 (2001). https://doi.org/10.1038/35067589
Massoulié, J.: The origin of the molecular diversity and functional anchoring of cholinesterases. Neurosignals 11, 130–143 (2002). https://doi.org/10.1159/000065054
doi: 10.1159/000065054 pubmed: 12138250
Xu, M.L., Luk, W.K.W., Lau, K.M., Bi, C.W.C., Cheng, A.W.M., Gong, A.G.W., Lin, H., Tsim, K.W.K.: Three N-Glycosylation Sites of Human Acetylcholinesterase Shares Similar Glycan Composition. J. Mol. Neurosci. 57, 486–491 (2015). https://doi.org/10.1007/S12031-015-0629-Z
doi: 10.1007/S12031-015-0629-Z pubmed: 26231935
Chen, V.P., Choi, R.C.Y., Chan, W.K.B., Leung, K.W., Guo, A.J.Y., Chan, G.K.L., Luk, W.K.W., Tsim, K.W.K.: The assembly of proline-rich membrane anchor (PRiMA)-linked acetylcholinesterase enzyme: glycosylation is required for enzymatic activity but not for oligomerization. J. Biol. Chem. 286, 32948–32961 (2011). https://doi.org/10.1074/JBC.M111.261248
doi: 10.1074/JBC.M111.261248 pubmed: 21795704 pmcid: 3190869
Giacobini, E.: Cholinergic function and Alzheimer’s disease. Int. J. Geriatr. Psychiatry. 18, (2003). https://doi.org/10.1002/GPS.935
Campanari, M.L., García-Ayllón, M.S., Blazquez-Llorca, L., Luk, W.K.W., Tsim, K., Sáez-Valero, J.: Acetylcholinesterase protein level is preserved in the Alzheimer’s brain. J. Mol. Neurosci. 53, 446–453 (2014). https://doi.org/10.1007/S12031-013-0183-5
doi: 10.1007/S12031-013-0183-5 pubmed: 24318838
Botella-López, A., Burgaya, F., Gavín, R., García-Ayllón, M.S., Gómez-Tortosa, E., Peña-Casanova, J., Ureña, J.M., Del Río, J.A., Blesa, R., Soriano, E., Sáez-Valero, J.: Reelin expression and glycosylation patterns are altered in Alzheimer’s disease. Proc. Natl. Acad. Sci. U. S. A. 103, 5573–5578 (2006). https://doi.org/10.1073/pnas.0601279103
doi: 10.1073/pnas.0601279103 pubmed: 16567613 pmcid: 1414634
Sáez-Valero, J., Sberna, G., McLean, C.A., Small, D.H.: Molecular isoform distribution and glycosylation of acetylcholinesterase are altered in brain and cerebrospinal fluid of patients with Alzheimer’s disease. J. Neurochem. 72, 1600–1608 (1999). https://doi.org/10.1046/J.1471-4159.1999.721600.X
doi: 10.1046/J.1471-4159.1999.721600.X pubmed: 10098867
Sáez-Valero, J., Sberna, G., McLean, C.A., Masters, C.L., Small, D.H.: Glycosylation of acetylcholinesterase as diagnostic marker for Alzheimer’s disease. Lancet (London, England). 350, 929 (1997). https://doi.org/10.1016/S0140-6736(97)24039-0
Fodero, L.R., Sáez-Valero, J., McLean, C.A., Martins, R.N., Beyreuther, K., Masters, C.L., Robertson, T.A., Small, D.H.: Altered glycosylation of acetylcholinesterase in APP (SW) Tg2576 transgenic mice occurs prior to amyloid plaque deposition. J. Neurochem. 81, 441–448 (2002). https://doi.org/10.1046/J.1471-4159.2002.00902.X
doi: 10.1046/J.1471-4159.2002.00902.X pubmed: 12065653
Botella-López, A., Cuchillo-Ibáñez, I., Cotrufo, T., Mok, S.S., Li, Q.-X., Barquero, M.-S., Dierssen, M., Soriano, E., Sáez-Valero, J.: β-amyloid controls altered Reelin expression and processing in Alzheimer’s disease. Neurobiol. Dis. 37, (2010). https://doi.org/10.1016/j.nbd.2009.12.006
Cuchillo-Ibáñez, I., Balmaceda, V., Botella-López, A., Rabano, A., Avila, J., Sáez-Valero, J.: Beta-amyloid impairs reelin signaling. PLoS ONE 8, e72297 (2013). https://doi.org/10.1371/journal.pone.0072297
doi: 10.1371/journal.pone.0072297 pubmed: 23951306 pmcid: 3741172
Cuchillo-Ibañez, I., Mata-Balaguer, T., Balmaceda, V., Arranz, J.J., Nimpf, J., Sáez-Valero, J.: The β-amyloid peptide compromises Reelin signaling in Alzheimer’s disease. Sci. Rep. 6, 31646 (2016). https://doi.org/10.1038/srep31646
doi: 10.1038/srep31646 pubmed: 27531658 pmcid: 4987719
Haukedal, H., Freude, K.K.: Implications of Glycosylation in Alzheimer’s Disease. Front. Neurosci. 14, (2021). https://doi.org/10.3389/FNINS.2020.625348
Boix, C.P., Lopez-Font, I., Cuchillo-Ibañez, I., Sáez-Valero, J.: Amyloid precursor protein glycosylation is altered in the brain of patients with Alzheimer’s disease. Alzheimers. Res. Ther. 12, (2020). https://doi.org/10.1186/S13195-020-00664-9
Pinho, S.S., Reis, C.A.: Glycosylation in cancer: mechanisms and clinical implications. Nat. Rev. Cancer. 15, 540–555 (2015). https://doi.org/10.1038/NRC3982
doi: 10.1038/NRC3982 pubmed: 26289314
Mereiter, S., Magalhães, A., Adamczyk, B., Jin, C., Almeida, A., Drici, L., Ibáñez-Vea, M., Gomes, C., Ferreira, J.A., Afonso, L.P., Santos, L.L., Larsen, M.R., Kolarich, D., Karlsson, N.G., Reis, C.A.: Glycomic analysis of gastric carcinoma cells discloses glycans as modulators of RON receptor tyrosine kinase activation in cancer. Biochim. Biophys. Acta. 1860, 1795–1808 (2016). https://doi.org/10.1016/J.BBAGEN.2015.12.016
doi: 10.1016/J.BBAGEN.2015.12.016 pubmed: 26721331
Duarte, H.O., Reis, C.A., Gomes, J.: Insights on ErbB glycosylation - contributions to precision oncology. Trends in cancer. 8, (2022). https://doi.org/10.1016/J.TRECAN.2022.02.003
Duarte, H.O., Rodrigues, J.G., Gomes, C., Hensbergen, P.J., Ederveen, A.L.H., de Ru, A.H., Mereiter, S., Polónia, A., Fernandes, E., Ferreira, J.A., van Veelen, P.A., Santos, L.L., Wuhrer, M., Gomes, J., Reis, C.A.: ST6Gal1 targets the ectodomain of ErbB2 in a site-specific manner and regulates gastric cancer cell sensitivity to trastuzumab. Oncogene 40, 3719–3733 (2021). https://doi.org/10.1038/S41388-021-01801-W
doi: 10.1038/S41388-021-01801-W pubmed: 33947960 pmcid: 8154592
Rodrigues, J.G., Duarte, H.O., Gomes, C., Balmaña, M., Martins, Á.M., Hensbergen, P.J., de Ru, A.H., Lima, J., Albergaria, A., van Veelen, P.A., Wuhrer, M., Gomes, J., Reis, C.A.: Terminal α2,6-sialylation of epidermal growth factor receptor modulates antibody therapy response of colorectal cancer cells. Cell. Oncol. (Dordr) 44, 835–850 (2021). https://doi.org/10.1007/S13402-021-00606-Z
doi: 10.1007/S13402-021-00606-Z
Freitas, D., Campos, D., Gomes, J., Pinto, F., Macedo, J.A., Matos, R., Mereiter, S., Pinto, M.T., Polónia, A., Gartner, F., Magalhães, A., Reis, C.A.: O-glycans truncation modulates gastric cancer cell signaling and transcription leading to a more aggressive phenotype. EBioMedicine 40, 349–362 (2019). https://doi.org/10.1016/J.EBIOM.2019.01.017
doi: 10.1016/J.EBIOM.2019.01.017 pubmed: 30662000 pmcid: 6413340
Mereiter, S., Balmaña, M., Campos, D., Gomes, J., Reis, C.A.: Glycosylation in the Era of Cancer-Targeted Therapy: Where Are We Heading? Cancer Cell 36, 6–16 (2019). https://doi.org/10.1016/J.CCELL.2019.06.006
doi: 10.1016/J.CCELL.2019.06.006 pubmed: 31287993
Siegel, R.L., Miller, K.D., Fuchs, H.E., Jemal, A.: Cancer statistics, 2022. CA. Cancer J. Clin. 72, 7–33 (2022). https://doi.org/10.3322/CAAC.21708
doi: 10.3322/CAAC.21708 pubmed: 35020204
Scott, E., Munkley, J.: Glycans as biomarkers in prostate cancer. Int. J. Mol. Sci. 20, (2019). https://doi.org/10.3390/IJMS20061389
Llop, E., Ferrer-Batallé, M., Barrabés, S., Guerrero, P.E., Ramírez, M., Saldova, R., Rudd, P.M., Aleixandre, R.N., Comet, J., de Llorens, R., Peracaula, R.: Improvement of Prostate Cancer Diagnosis by Detecting PSA Glycosylation-Specific Changes. Theranostics. 6, 1190–1204 (2016). https://doi.org/10.7150/THNO.15226
doi: 10.7150/THNO.15226 pubmed: 27279911 pmcid: 4893645
Ferrer-Batallé, M., Llop, E., Ramírez, M., Aleixandre, R.N., Saez, M., Comet, J., de Llorens, R., Peracaula, R.: Comparative study of blood-based biomarkers, α2,3-Sialic Acid PSA and PHI, for high-risk prostate cancer detection. Int. J. Mol. Sci. 18, (2017). https://doi.org/10.3390/IJMS18040845
Paul, A., Frenkel-Pinter, M., Escobar Alvarez, D., Milordini, G., Gazit, E., Zacco, E., Segal, D.: Tryptophan-galactosylamine conjugates inhibit and disaggregate amyloid fibrils of Aβ42 and hIAPP peptides while reducing their toxicity. Commun. Biol. 3, (2020). https://doi.org/10.1038/S42003-020-01216-5
Barb, A.W., Falconer, D.J., Subedi, G.P.: The Preparation and Solution NMR Spectroscopy of Human Glycoproteins Is Accessible and Rewarding. Methods Enzymol. 614, 239–261 (2019). https://doi.org/10.1016/BS.MIE.2018.08.021
doi: 10.1016/BS.MIE.2018.08.021 pubmed: 30611426
Yamaguchi, Y., Kato, K.: Dynamics and interactions of glycoconjugates probed by stable-isotope-assisted NMR spectroscopy. Methods Enzymol. 478, 305–322 (2010). https://doi.org/10.1016/S0076-6879(10)78015-0
doi: 10.1016/S0076-6879(10)78015-0 pubmed: 20816487
Lee, J.H., Lee, K.: Stable Isotope Labeling of Proteins in Mammalian Cells. J. Korean Magn. Reson. Soc. 24, 77–85 (2020). https://doi.org/10.6564/JKMRS.2020.24.3.077
doi: 10.6564/JKMRS.2020.24.3.077
Fuccio, C., Luchinat, E., Barbieri, L., Neri, S., Fragai, M.: Algal autolysate medium to label proteins for NMR in mammalian cells. J. Biomol. NMR. 64, 275–280 (2016). https://doi.org/10.1007/S10858-016-0026-0
doi: 10.1007/S10858-016-0026-0 pubmed: 27106902
Lenza, M.P., Oyenarte, I., Diercks, T., Quintana, J.I., Gimeno, A., Coelho, H., Diniz, A., Peccati, F., Delgado, S., Bosch, A., Valle, M., Millet, O., Abrescia, N.G.A., Palazón, A., Marcelo, F., Jiménez-Osés, G., Jiménez-Barbero, J., Ardá, A., Ereño-Orbea, J.: Structural Characterization of N-Linked Glycans in the Receptor Binding Domain of the SARS-CoV-2 Spike Protein and their Interactions with Human Lectins. Angew. Chem. Int. Ed. Engl. 59, 23763–23771 (2020). https://doi.org/10.1002/ANIE.202011015
doi: 10.1002/ANIE.202011015 pubmed: 32915505 pmcid: 7894318
Unione, L., Lenza, M.P., Ardá, A., Urquiza, P., Laín, A., Falcón-Pérez, J.M., Jiménez-Barbero, J., Millet, O.: Glycoprofile Analysis of an Intact Glycoprotein As Inferred by NMR Spectroscopy. ACS Cent. Sci. 5, 1554–1561 (2019). https://doi.org/10.1021/ACSCENTSCI.9B00540/SUPPL_FILE/OC9B00540_SI_001.PDF
doi: 10.1021/ACSCENTSCI.9B00540/SUPPL_FILE/OC9B00540_SI_001.PDF pubmed: 31572782 pmcid: 6764210
Hong, S.H., Shin, J.S., Chung, H., Park, C.G.: Galectin-4 interaction with CD14 triggers the differentiation of monocytes into macrophage-like cells via the MAPK signaling pathway. Immune Netw. 19, (2019). https://doi.org/10.4110/IN.2019.19.E17

Auteurs

Esther Llop (E)

Department of Biology, Biochemistry and Molecular Biology Unit, University of Girona, 17003, Girona, Spain.

Ana Ardá (A)

Ikerbasque, Basque Foundation for Science, Maria Diaz de Haro 3, 48013 Bilbao, Bizkaia, Spain.
CIC bioGUNE, Basque Research & Technology Alliance, Bizkaia Technology Park, Bld. 800, 48160, Derio, Bizkaia, Spain.

Elsa Zacco (E)

Italian Institute of Technology, Genova, Italy.

Roisin O'Flaherty (R)

Department of Chemistry, Maynooth University, Maynooth, Co. Kildare, Ireland.

María-Salud García-Ayllón (MS)

Laboratorio de Investigación, Hospital General Universitario de Elche, Fundació para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana, Alicante, Spain.
Instituto de Neurociencias de Alicante, Universidad Miguel Hernández de Elche-CSIC, Sant Joan d'Alacant, Spain.
Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.

Massimo Aureli (M)

Department of Medical Biotechnology and Translational Medicine, University of Milano, via Fratelli Cervi 93, 20090, Segrate, MI, Italy.

Moran Frenkel-Pinter (M)

The Center for Nanoscience and Nanotechnology, Institute of Chemistry, The Hebrew University of Jerusalem, Jerusalem, Israel.

Celso A Reis (CA)

Instituto de Investigação E Inovação Em Saúde, Universidade Do Porto, Porto, Portugal.
Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal.
Instituto de Ciências Biomédicas Abel Salazar (ICBAS), Universidade Do Porto, Porto, Portugal.

Ole K Greiner-Tollersrud (OK)

Institute of Medical Biology, UiT The Arctic University of Norway, Tromsø, Norway.

Inmaculada Cuchillo-Ibáñez (I)

Instituto de Neurociencias de Alicante, Universidad Miguel Hernández de Elche-CSIC, Sant Joan d'Alacant, Spain. icuchillo@umh.es.
Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain. icuchillo@umh.es.
Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain. icuchillo@umh.es.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH